Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK9 inhibitors(Cyclin-dependent kinase 9 inhibitors), FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H26N6 |
InChIKeyOVOYRPVIZNJKHS-MXVIHJGJSA-N |
CAS Registry2241659-94-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | AU | 22 Feb 2022 |